Viridian Therapeutics Ors Inc (VRDN)

Investing Cash Flow

-$367.24M

TTM · Period ending: · USD

VRDN logo

VRDN Investing Cash Flow

Latest reported-$367.24M
VRDN TTM Cash from Investing ($5.69K → -$367.24M)
High-resolution chart · PNG

VRDN investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Viridian Therapeutics Ors Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-367,239,000
-60,364,000
-37,563,000
238,942,000
28,198,000
14,456,000
-228,651,000
-335,447,000
-202,739,000
-224,002,000
-94,252,000
-105,144,000
-110,534,000
-137,284,000
-115,126,000
-14,733,000
-51,133,000
-76,301,000
-74,292,000
-46,511,000
-52,815,000
-41,610,000
-50,481,000
8,948,000
20,022,000
33,047,000
28,226,000
30,317,000
13,282,000
-32,632,000
-29,907,000
-39,032,000
-33,081,000
-297,000
1,034,000
2,068,000
5,106,000
1,091,000
-148,000
-1,171,000
-4,150,000
-54,000
-95,000
-333,384
-337,713
-317,981
-274,000
-15,258
-9,100
5,691
5,685
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.